BioSpace News Archive

Aesculap, Inc. is pleased to announce the asset acquisition of Dextera Surgical Inc.

Biologics, Inc., a McKesson Specialty Health oncology and complex care pharmacy services company, has been selected by the Janssen Pharmaceutical Companies of Johnson & Johnson to be in the limited distribution network for ERLEADA™ (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer (NM-CRPC).

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced it has entered into an exclusive agreement with Sam Chun Dang Pharm. Co. Ltd. (SCD), to develop, manufacture and market a portfolio of ophthalmic products in the U.S. and Canada.

Endologix, Inc. announced today that John McDermott is stepping down as the Company’s Chief Executive Officer.

Insulet Corporation today announced financial results for the three months and full year ended December 31, 2017.

bluebird bio, Inc. today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2017.

Advaxis, Inc. announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the company’s Leap-In cell line development tools.

Anika Therapeutics, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2017, along with business progress in the periods.

Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock